Best Researcher Award
Rowan Arida of Alamein International University, Egypt, is recognized through the Technology Scientists Awards for scholarly contributions to neuropharmacology. Her published research investigates mechanisms of neuroinflammation, organophosphate toxicity, mitochondrial dysfunction, metabolic impairment, and therapeutic strategies for neurodegenerative disorders. The award acknowledges the scientific relevance, emerging research profile, and growing contribution reflected through peer-reviewed publications and recognized scholarly databases.[1]
Abstract
Rowan Arida has established an emerging academic profile in neuropharmacology through investigations of organophosphate-induced neurotoxicity, mitochondrial dysfunction, neuroinflammation, metabolic impairment, and therapeutic strategies for neurodegenerative diseases. Her publications combine molecular biology, proteomics, and pharmacological approaches to understand neuronal injury and identify potential interventions. The research demonstrates interdisciplinary collaboration while addressing biomedical challenges associated with environmental toxicology and neurological disorders. Recognition through the Technology Scientists Awards reflects the quality, scientific relevance, and future promise of these peer-reviewed contributions within modern neuroscience and pharmacological research communities.[1][2][3]
Keywords
Neuropharmacology, Neuroinflammation, Organophosphate Toxicity, Endocannabinoid System, Mitochondrial Dysfunction, Proteomics, LC-MS/MS, Neurodegenerative Diseases, Metabolic Impairment, Synaptic Dysfunction, Therapeutic Targets, Biomedical Research.
Introduction
Rowan Arida conducts research focused on neuropharmacology, emphasizing mechanisms underlying neurotoxicity, inflammation, and metabolic dysfunction. Her investigations integrate experimental pharmacology with molecular analysis to improve understanding of neurological disorders and potential therapeutic interventions while contributing to contemporary biomedical knowledge through peer-reviewed scientific publications.[1]
Research Profile
Affiliated with Alamein International University, Rowan Arida has developed a focused publication portfolio addressing neuropharmacology and toxicological neuroscience. Her scholarly profile includes Scopus-indexed research exploring molecular mechanisms of neuronal injury, proteomic analysis, and regulated cell death pathways relevant to neurological disease progression.[2]
Research Contributions
Her research contributes evidence linking organophosphate exposure with neuroinflammation, mitochondrial dysfunction, synaptic impairment, and metabolic abnormalities. These findings advance understanding of disease mechanisms while supporting investigation of therapeutic targets capable of reducing neuronal damage and improving outcomes in neurodegenerative disorders.[1][3]
Publications
Published studies examine endocannabinoid system perturbation, hippocampal mitochondrial dysfunction, proteomic biomarkers, and therapeutic approaches targeting regulated cell death. Collectively, these articles demonstrate consistent engagement with neuroscience, molecular pharmacology, and translational biomedical research addressing significant neurological and metabolic health challenges.[1][2][3]
Research Impact
Although representing an early-stage publication record, the research provides valuable mechanistic insights supporting future investigations into neurodegenerative diseases and environmental toxicology. The interdisciplinary methodology enhances scientific relevance and establishes a foundation for continued collaboration, innovation, and evidence-based therapeutic development.[2]
Award Suitability
Recognition through the Best Researcher Award appropriately acknowledges Rowan Arida’s contributions to neuropharmacology, emphasizing scientific rigor, interdisciplinary investigation, and promising research addressing neurological disorders. The published work demonstrates commitment to advancing biomedical understanding while supporting future innovation within neuroscience and pharmacological sciences.[3]
Conclusion
Rowan Arida’s scholarly activities reflect focused investigation into neuropharmacological mechanisms associated with neurotoxicity and neurodegeneration. Through peer-reviewed publications and interdisciplinary methodologies, her research contributes meaningful scientific knowledge while demonstrating continued potential for advancing biomedical science, therapeutic discovery, and translational neuroscience research.[1][3]
External Links
References
- Arida, R., et al. (2025). Role of Endocannabinoid System Perturbation in Organophosphate-Mediated Metabolic Impairment and Neuroinflammation. Scopus Indexed Publication.
https://www.scopus.com/pages/publications/105029756599
- Arida, R., et al. (2025). Hippocampal Mitochondrial Dysfunction and Synaptic Disruption Link Organophosphate Exposure to Pre-Diabetes: An LC-MS/MS-Based Proteomics Approach. Biomolecules, 16(7), 952.
https://www.mdpi.com/2218-273X/16/7/952
- Arida, R., et al. (2025). Therapeutic Approaches Targeting Regulated Cell Death in Neurodegenerative Diseases: Current Understanding and Recent Advances in Combating Neuronal Loss. Scopus Indexed Publication.
https://www.scopus.com/pages/publications/105019730290
